Sbi Healthcare Opportunities Fund
Holdings
36
Concentrated
Top 10 weight
56%
Concentration
Strategy data
N/A
Not reported
Equity
98%
Asset allocation
Portfolio
4Sectors
4Large positions
64.6%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap40%
Mid cap23%
Small cap33%
Asset allocation
Equity98%
Top holdings
12.7%
Divi's Laboratories Ltd.EQUITY
7.5%Acutaas Chemicals Ltd.EQUITY
5.2%Cipla Ltd.EQUITY
5.1%5.0%
4.7%
4.6%
Laurus Labs Ltd.EQUITY
4.0%Aurobindo Pharma Ltd.EQUITY
3.9%3.7%
Biocon Ltd.EQUITY
3.0%2.9%
Anthem Biosciences Ltd.EQUITY
2.8%Gland Pharma Ltd.EQUITY
2.8%Fortis Healthcare Ltd.EQUITY
2.6%TREPSDERIVATIVE
2.6%Sai Life Sciences Ltd.EQUITY
2.4%Aether Industries Ltd.EQUITY
2.3%Sudeep Pharma Ltd.EQUITY
2.2%Polymedicure Ltd.EQUITY
2.0%Ajanta Pharma Ltd.EQUITY
1.9%Concord Biotech Ltd.EQUITY
1.9%Mankind Pharma Ltd.EQUITY
1.8%Lupin Ltd.EQUITY
1.8%1.7%
Global Health Ltd.EQUITY
1.7%1.2%
Dr. Lal Path labs Ltd.EQUITY
1.1%Abbott India Ltd.EQUITY
1.0%0.96%
0.85%
0.73%
Gufic Biosciences Ltd.EQUITY
0.36%0.05%
Net Receivable / PayableDERIVATIVE
-0.9%AI Smart summary
Portfolio read
- 98% equity.
- 36 disclosed positions across 4 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 64.6% of the portfolio.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 65%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
HDFC Manufacturing fund91 holdings · 34% top 10 · 80% AS
UTI Quant Fund89 holdings · 36% top 10
Icici Prudential Energy Opportunities Fund88 holdings · 43% top 10 · 83% AS
ICICI Prudential Business Cycle Fund86 holdings · 50% top 10 · 70% AS
Edelweiss Technology Fund84 holdings · 54% top 10
Axis Business Cycles Fund81 holdings · 29% top 10 · 67% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
64.6%
27.2%
4.5%
2.0%